香菇多糖-蒙花苷自组装纳米粒的制备、药动学和急性毒性评价OA
Lentinan-buddleoside self-assembled nanoparticles:Preparation,pharmacokinetics and acute toxicity evaluation
目的 制备香菇多糖-蒙花苷自组装纳米粒(lentinan-buddleoside self-assembled nanoparticles,Len-Bud-SANs),考察理化性质及口服药动学行为,并评价急性毒性.方法 采用自组装法制备 Len-Bud-SANs.以包封率、载药量和粒径为指标,单因素实验结合 Box-Behnken 设计-效应面法(Box-Behnken design-response surface methodology,BBD-RSM)优化 Len-Bud-SANs处方工艺.透射电子显微镜(transmission electron microscope,TEM)观察 Len-Bud-SANs外貌形态,X 射线粉末衍射(X-ray powder diffraction,XRPD)法分析 Len-Bud-SANs 粉末晶型.分子模拟对接和傅里叶变换红外光谱(Fourier transform infrared spectroscopy,FTIR)研究香菇多糖和蒙花苷结合机制.测定 Len-Bud-SANs在 pH 2.0 和 pH 6.8 磷酸盐缓冲液(PBS)中溶解度及释药行为.SD 大鼠分别 ig 给予蒙花苷和 Len-Bud-SANs 粉末,HPLC 法测定血药浓度,计算主要药动学参数.以体质量、摄食量、胸腺指数和脾脏指数为指标,对 Len-Bud-SANs粉末进行安全性评价.苏木精-伊红(HE)染色观察 SD大鼠重要器官病理情况.结果 Len-Bud-SANs 最佳处方:香菇多糖质量分数为 0.39%,制备温度为 65.00℃,制备时间为1.50 h.Len-Bud-SANs的包封率、载药量、粒径和 ζ 电位分别为(88.57±0.83)%、(8.02±0.11)%、(57.54±4.90)nm和(-32.10±1.36)mV.Len-Bud-SANs 微观外貌为球形,蒙花苷在 Len-Bud-SANs 粉末中转变为无定形态.Len-Bud-SANs 在pH 2.0 和 p H 6.8 PBS 中溶解度分别提高至 59.89 倍和 42.95 倍,累积释放率分别提高至 90.80%和 91.73%,释药过程符合Weibull 模型.药动学结果显示,Len-Bud-SANs半衰期(t1/2)增加至(4.45±0.80)h,血药浓度(Cmax)和时间曲线下面积(AUC0~t)分别提高至 3.00 倍和 5.60 倍.与空白组相比,Len-Bud-SANs组体质量、摄食量、胸腺指数、脾脏指数及重要器官病理均无明显变化.结论 Len-Bud-SANs显著促进了蒙花苷口服吸收,未见明显毒性,为后续开发研究奠定基础.
Objective To prepare lentinan-buddleoside self-assembled nanoparticles(Len-Bud-SANs),and evaluate investigate its physicochemical properties,oral pharmacokinetic behavior and acute toxicity.Methods Len-Bud-SANs were prepared by self-assembled method.Envelopment efficiency,drug loading and particle size were employed as indicators,single factor experiments combined with Box-Behnken design-response surface method(BBD-RSM)were used to obtainoptimal prescriptions of Len-Bud-SANs.The appearance of Len-Bud-SANs was observed by transmission electron microscope(TEM)was,crystal form of Len-Bud-SANs powder was analyzed by X-ray powder diffraction(XRPD).Molecular simulation docking and Fourier transform infrared spectroscopy(FTIR)were used to study the binding mechanism between lentinan and buddleoside.The solubility and drug release behavior of Len-Bud-SANs were determined in phosphate buffer solution(PBS)at pH 2.0 and pH 6.8.SD rats in each group were administered intragastrically with buddleoside suspension and Len-Bud-SANs powder,then buddleoside concentration in plasma was analyzed by HPLC method,and main pharmacokinetic parameters were calculated.Safety evaluation of Len-Bud-SANs powder was performed by indicators of body weight,food intake,thymus index and spleen index.Pathological conditions of the important organs were observed by hematoxylin-eosin(HE)staining.Results Optimal formulation of Len-Bud-SANs:mass fraction of lentinan was 0.39%,preparation temperature was 65.00℃,and preparation time was 1.50 h.Envelopment efficiency,drug loading,particle size and ζ potential were(88.57±0.83)%,(8.02±0.11)%,(57.54±4.90)nm and(-32.10±1.36)mV,respectively.Microscopic appearance of Len-Bud-SANs was spherical,and buddleoside existed as an amorphous form in Len-Bud-SANs powder.Solubility of Len-Bud-SANs in phosphate buffer solution of pH 2.0 and pH 6.8 was increased to 59.89 times and 42.95 times,and cumulative release rate were increased to 90.80%and 91.73%,respectively.Drug release behavior of Len-Bud-SANs conformed to Weibull model.Oral pharmacokinetic results showed that t1/2 of Len-Bud-SANs was increased to(4.45±0.80)h,Cmax and AUC0—t were increased to 3.00-fold and 5.60-fold.Compared with the blank group,there was no significant change in body weight,food intake,thymus index,spleen index and pathology of important organs in the Len-Bud-SANs group.Conclusion Len-Bud-SANs significantly promoted oral absorption of buddleoside effectively,and no obvious toxicity was observed,which laid the foundation for subsequent research and development.
李晓蒙;高青;王改利;崔晓鸽;郑妩媚;万亚存;付珍娜;李阳杰
郑州健康学院,河南 郑州 450064郑州健康学院,河南 郑州 450064郑州健康学院,河南 郑州 450064郑州健康学院,河南 郑州 450064郑州健康学院,河南 郑州 450064郑州健康学院,河南 郑州 450064河南中医药大学,河南 郑州 450046新疆科技学院,新疆 库尔勒 841010
医药卫生
蒙花苷自组装纳米粒Box-Behnken设计-效应面法溶解度释药行为药动学生物利用度急性毒性
buddleosideself-assemblednanoparticlesBox-Behnken response surface design methodsolubilitydrug release behaviorpharmacokineticbioavailabilityacute toxicity
《中草药》 2026 (10)
3778-3791,14
新疆维吾尔自治区"天池英才"引进计划(XJGXJGZH-2024032)2025年校级重点培育科研项目(2025-XJKY-06)新疆科技学院科研基金创新团队专项(2024-KYTD02)
评论